ST
AMAG

Spot Trading’s AMAG Pharmaceuticals AMAG Stock Holding History

Spot Trading’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-32,275
Closed -$791K – 3340
2016
Q3 		$791K Buy
32,275
+19,263
+148% +$481K 0.02% 1215
2016
Q2 		$311K Buy
+13,012
New +$298K 0.01% 1926
2015
Q2 		– Sell
-5,293
Closed -$289K – 4383
2015
Q1 		$289K Buy
+5,293
New +$252K ﹤0.01% 2505
2014
Q3 		– Sell
-165
Closed -$3K – 4868
2014
Q2 		$3K Buy
+165
New +$3.05K ﹤0.01% 4419

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Spot Trading's AMAG Position: Q4 2016 in Review

Spot Trading sold out of AMAG Pharmaceuticals (AMAG) in Q4 2016, closing a stake of 32,275 shares — an estimated $791K sold.

Spot Trading first reported a position in AMAG in Q2 2014 and held it in 4 quarters. The position peaked at $791K in Q3 2016. 206 funds tracked by Wall St. Rank hold AMAG as of Q4 2016.

  • Spot Trading reported no remaining AMAG Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Spot Trading sold 32,275 AMAG Pharmaceuticals shares in Q4 2016, an estimated $791K.
  • Spot Trading first reported a position in AMAG Pharmaceuticals in Q2 2014 and held it in 4 quarters.
  • Spot Trading's AMAG Pharmaceuticals position peaked at $791K in Q3 2016.
  • 206 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.